other material
confidence high
sentiment neutral
materiality 0.50
Valion Bio signs $50,000 Third Side Letter with 3i for Series B preferred shares and warrants
Valion Bio, Inc.
- Valion Bio and 3i, LP entered a Third Side Letter on Oct. 7, 2026, for a $50,000 closing under the Series B Preferred Purchase Agreement.
- 3i agreed to purchase 50 Series B Preferred Shares and Series B Warrants for 1,539 common shares at an initial exercise price of $2.5520 per share.
- The shares and warrants were issued under Section 4(a)(2)/Rule 506(b); Item 3.02 reports the unregistered sales of equity securities.
- The Third Side Letter is Exhibit 10.1; closing conditions include Series B conditions, deliverables, price-adjustment notice, and Nasdaq listing compliance.
- 3i previously purchased 13,637 Series C Preferred Shares for $13,637,000 and holds a $16,253,147.10 note plus Note Warrant for 182,129 shares.